Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 1
2006 2
2008 3
2010 1
2012 1
2013 4
2014 2
2015 1
2016 1
2017 1
2018 4
2019 4
2020 4
2021 2
2022 3
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
Pollyea DA, Bixby D, Perl A, Bhatt VR, Altman JK, Appelbaum FR, de Lima M, Fathi AT, Foran JM, Gojo I, Hall AC, Jacoby M, Lancet J, Mannis G, Marcucci G, Martin MG, Mims A, Neff J, Nejati R, Olin R, Percival ME, Prebet T, Przespolewski A, Rao D, Ravandi-Kashani F, Shami PJ, Stone RM, Strickland SA, Sweet K, Vachhani P, Wieduwilt M, Gregory KM, Ogba N, Tallman MS. Pollyea DA, et al. Among authors: ravandi kashani f. J Natl Compr Canc Netw. 2021 Jan 6;19(1):16-27. doi: 10.6004/jnccn.2021.0002. J Natl Compr Canc Netw. 2021. PMID: 33406488
Hematologic malignancies and Li-Fraumeni syndrome.
Swaminathan M, Bannon SA, Routbort M, Naqvi K, Kadia TM, Takahashi K, Alvarado Y, Ravandi-Kashani F, Patel KP, Champlin R, Kantarjian H, Strong L, DiNardo CD. Swaminathan M, et al. Among authors: ravandi kashani f. Cold Spring Harb Mol Case Stud. 2019 Feb 1;5(1):a003210. doi: 10.1101/mcs.a003210. Print 2019 Feb. Cold Spring Harb Mol Case Stud. 2019. PMID: 30709875 Free PMC article. Review.
CPX-351 (vyxeos) in AML.
Alfayez M, Kantarjian H, Kadia T, Ravandi-Kashani F, Daver N. Alfayez M, et al. Among authors: ravandi kashani f. Leuk Lymphoma. 2020 Feb;61(2):288-297. doi: 10.1080/10428194.2019.1660970. Epub 2019 Sep 24. Leuk Lymphoma. 2020. PMID: 31547736 Review.
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia.
Cerchione C, Romano A, Daver N, DiNardo C, Jabbour EJ, Konopleva M, Ravandi-Kashani F, Kadia T, Martelli MP, Isidori A, Martinelli G, Kantarjian H. Cerchione C, et al. Among authors: ravandi kashani f. Front Oncol. 2021 Mar 29;11:639387. doi: 10.3389/fonc.2021.639387. eCollection 2021. Front Oncol. 2021. PMID: 33898313 Free PMC article. Review.
The pharmacological management of hairy cell leukemia.
Ramos Perez J, Ravandi-Kashani F. Ramos Perez J, et al. Among authors: ravandi kashani f. Expert Opin Pharmacother. 2020 Aug;21(11):1337-1344. doi: 10.1080/14656566.2020.1754397. Epub 2020 May 7. Expert Opin Pharmacother. 2020. PMID: 32378970 Review.
Non-intensive acute myeloid leukemia therapies for older patients.
Babakhanlou R, Ravandi-Kashani F. Babakhanlou R, et al. Among authors: ravandi kashani f. Expert Rev Hematol. 2023 Mar;16(3):171-180. doi: 10.1080/17474086.2023.2184342. Epub 2023 Mar 2. Expert Rev Hematol. 2023. PMID: 36864772 Review.
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.
Nguyen D, Kantarjian HM, Short NJ, Qiao W, Ning J, Cuglievan B, Daver NG, DiNardo CD, Jabbour EJ, Kadia TM, Borthakur G, Garcia-Manero G, Konopleva MY, Andreeff M, Ravandi-Kashani F, Sasaki K, Issa GC. Nguyen D, et al. Among authors: ravandi kashani f. Cancer. 2023 Jun 15;129(12):1856-1865. doi: 10.1002/cncr.34728. Epub 2023 Mar 9. Cancer. 2023. PMID: 36892949
37 results